How a Drug Works Better in Low Oxygen Conditions
Author Information
Author(s): Saunders M P, Patterson A V, Chinje E C, Harris A L, Stratford I J
Primary Institution: Department of Pharmacy and Pharmaceutical Sciences, University of Manchester
Hypothesis
Can NADPH:cytochrome c (P450) reductase restore the effectiveness of tirapazamine in resistant lung cancer cells?
Conclusion
The study found that reintroducing P450R activity in resistant lung cancer cells restored their sensitivity to tirapazamine under both aerobic and hypoxic conditions.
Supporting Evidence
- Tirapazamine is activated in low oxygen conditions to kill cancer cells.
- A549c50 cells showed reduced sensitivity to tirapazamine due to low P450R activity.
- Restoring P450R activity in A549c50 cells made them sensitive to tirapazamine again.
Takeaway
Researchers found a way to make a cancer drug work better by adding back a missing enzyme in cancer cells. This helps the drug kill more cancer cells, even when there's not much oxygen.
Methodology
The study involved transfecting resistant A549 lung cancer cells with the cDNA for human P450R to restore enzyme activity.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website